The Motley Fool

MARCH 19, 2024

Shares of ACM Research (NASDAQ: ACMR) were falling sharply today in a broad-based sell-off in artificial intelligence (AI) stocks following Nvidia 's GTC Conference kickoff yesterday as the "sell-the-news" event seemed to lead to some of the air coming out of the AI rally. What's next for ACM Research?

Shareholders 130

Shareholders Capital Funds Returns 130

The Motley Fool

FEBRUARY 28, 2024

Shares of ACM Research (NASDAQ: ACMR) were surging today after the semiconductor cleaning equipment maker posted standout results in its fourth-quarter earnings report. Should you invest $1,000 in ACM Research right now? See the 10 stocks *Stock Advisor returns as of February 26, 2024 Jeremy Bowman has positions in ACM Research.

Accounting 130

Accounting Returns Portfolios Companies 130

PE Hub

JANUARY 26, 2024

Clinical research is increasingly catching the interest of PE investors; PE Hub has seen a flurry of deals in recent months. The post Webster prepping sale of CenExel Clinical Research, sources say appeared first on PE Hub.

Investors 186

Investors 186

PE Hub

FEBRUARY 20, 2024

Think Research is a Toronto-based digital health software service provider. The post Beedie Capital agrees to take Think Research private appeared first on PE Hub.

Capital 147

Capital 147

PE Hub

DECEMBER 14, 2023

The post Thoma Bravo to invest in investment research platform BlueMatrix appeared first on PE Hub. The transaction is expected to close by the beginning of January 2024.

Investing 208

Investing 208

The Motley Fool

JANUARY 9, 2024

Shares of ACM Research (NASDAQ: ACMR) were moving higher today after the company updated its full-year guidance for 2023 and gave better-than-expected guidance for 2024. ACM surprises to the upside ACM Research makes wafer-cleaning equipment for the semiconductor industry and it occupies a unique niche in the sector. as of 12:10 p.m.

Returns 130

Returns Portfolios Investors Companies 130

The Motley Fool

MARCH 20, 2024

They spotlight Lam Research (NASDAQ: LRCX) , a titan in semiconductor equipment, Oracle (NYSE: ORCL) , a cloud-computing giant pivoting to AI, and Micron Technology (NASDAQ: MU) , a key player in the indispensable memory sector. Billy Duberstein has positions in Alphabet, Amazon, Lam Research, Micron Technology, and Microsoft.

Investing 245

Investing Bidding Leveraging Prospects 245

Private Equity Info

OCTOBER 25, 2023

Learn how our M&A research database can accelerate your deal flow. Find answers to common questions about our powerful tools, data accuracy, and personalized customer service. Schedule a demo today!

Deal Flow 219

Deal Flow 219

PE Hub

NOVEMBER 21, 2023

The post LLCP bids adieu to Therapeutic Research Center appeared first on PE Hub. TRC is an independent, evidence-based education and training provider.

Bidding 183

Bidding Education 183

PE Hub

MAY 19, 2023

The post NMS recaps clinical research sites AMC Research and Central Research Associates appeared first on PE Hub. AMC was founded by Dr. Reza Bolouri while CRA was founded by Dr. William Whitley in 2016.

120

120

The Motley Fool

JULY 27, 2023

With that as a backdrop, on Thursday chipmaking tools supplier Lam Research (NASDAQ: LRCX) surged 9.3%, semiconductor equipment systems provider ASML Holding (NASDAQ: ASML) rallied 3.5%, and chipmaker Advanced Micro Devices (NASDAQ: AMD) closed the trading day up by 1%. and Lam Research wasn't one of them! Image source: Getty Images.

Prospects 245

Prospects Stock Market Stock Market Investors 245

PE Hub

SEPTEMBER 20, 2023

The post Avante backs New Harbor’s buyout of Monroe Biomedical Research appeared first on PE Hub. Based in Chicago, New Harbor invests in lower middle-market healthcare, education, and technology-enabled services businesses.

Buyout 218

Buyout Education Investing 218

The Motley Fool

APRIL 18, 2024

The stock of semiconductor equipment maker Lam Research (NASDAQ: LRCX) has done very well of late (it's up 87% over the past year), yet one pundit tracking the company believes it can go even higher. In my view, Lam Research is the right business at the right time to take advantage. Should you invest $1,000 in Lam Research right now?

Returns 130

Returns Portfolios Companies Investors 130

PE Hub

OCTOBER 4, 2023

Eximia is a multi-therapeutic, clinical trial research company. The post VSS Capital invests in Eximia Research Network appeared first on PE Hub.

Capital Investments 180

Capital Investments Capital Investing Companies 180

PE Hub

NOVEMBER 28, 2023

ECIR is a clinical research site management organization. The post Gauge Capital invests in East Coast Institute for Research appeared first on PE Hub.

Capital Investments 171

Capital Investments Capital Investing 171

The Motley Fool

OCTOBER 27, 2023

Shares of ACM Research (NASDAQ: ACMR) , which makes equipment to clean semiconductor wafers, were taking a dive today after the company provided disappointing preliminary revenue numbers. What's next for ACM Research In the second-quarter report, ACM called for revenue of $515 million to $585 million, or 41% revenue growth at the midpoint.

Prospects 130

Prospects Companies Returns Investors 130

PE Hub

JUNE 13, 2023

The firm also plans on acquiring add-ons in partnership with Centricity Research. The post Trinity Hunt eyes consolidation with Centricity Research investment appeared first on PE Hub.

Investing 195

Investing 195

The Motley Fool

JULY 7, 2023

Lam Research (NASDAQ: LRCX) stock dropped 41% in 2022 after weathering a host of challenges, including inflation, a rising interest rate environment, U.S. As a result, the first half of 2023 has seen Lam Research's stock jump 54%. 10 stocks we like better than Lam Research When our analyst team has a stock tip, it can pay to listen.

Investors 246

Investors Returns Investing Companies 246

The Motley Fool

DECEMBER 8, 2023

Shares of ACM Research (NASDAQ: ACMR) were gaining last month as the company known for making equipment that cleans semiconductor wafers posted solid results in its third-quarter earnings report and benefited from a broader rebound in the stock market and in chip stocks. Should you invest $1,000 in ACM Research right now?

Exchange-Traded Funds 130

Exchange-Traded Funds Stock Market Stock Market Returns 130

The Motley Fool

SEPTEMBER 3, 2023

While everyone's situation is different, data shows that there is a particularly bad age to begin claiming benefits -- but there's an important caveat to consider before taking this research to heart. In 2019, researchers at United Income studied retirees' claiming ages and how it affected their lifetime income.

Financing 246

Financing Finance 246

PE Hub

SEPTEMBER 15, 2023

Flourish Research is a provider of clinical trials with multiple locations in the U.S. The post NMS Capital-backed Flourish Research acquires Valley Clinical Trials appeared first on PE Hub.

Capital 162

Capital 162

Private Equity Professional

NOVEMBER 29, 2023

Levine Leichtman Capital Partners (LLCP) has sold Therapeutic Research Center to Colibri Group, a portfolio company of Gridiron Capital.

Capital 130

Capital Portfolios Companies 130

Private Equity Professional

NOVEMBER 28, 2023

Levine Leichtman Capital Partners (LLCP) has sold Therapeutic Research Center to Colibri Group, a portfolio company of Gridiron Capital.

Capital 130

Capital Portfolios Companies 130

The Motley Fool

JULY 28, 2023

Leading equipment maker Lam Research (NASDAQ: LRCX) popped as much as 16.1% Shares of Lam Research are now up 74% this year and are back above all-time highs set during the pandemic bull market. Shares of Lam Research are now up 74% this year and are back above all-time highs set during the pandemic bull market.

Returns 130

Returns Companies Investors Investing 130

PE Hub

MAY 31, 2023

The post Trinity Hunt invests in clinical trial network Centricity Research appeared first on PE Hub. McGuireWoods served as legal advisor to Trinity Hunt on the deal.

Legal 188

Legal Investing 188

Private Equity Insights

DECEMBER 14, 2023

Thoma Bravo, a leading software investment firm, today announced it has signed a definitive agreement to make a strategic growth investment in BlueMatrix, a leading end-to-end content creation and distribution platform for investment research providers. Terms of the transaction were not disclosed.

Investing 130

Investing Legal Investment Banking Investment Banks 130

PE Hub

JUNE 22, 2023

The post Broadtree Partners buys GovCon platform Joint Research and Development appeared first on PE Hub. With this acquisition, JRAD becomes the second company in Broadtree's GovCon platform, joining Sayres Defense.

Companies 178

Companies 178

The Motley Fool

OCTOBER 9, 2023

What happened Lam Research 's (NASDAQ: LRCX) stock price dropped by 10.5% As an important supplier to chip makers, Lam Research was a victim of those broader trends. As an important supplier to chip makers, Lam Research was a victim of those broader trends. in September, according to S&P Global Market Intelligence.

Prospects 130

Prospects Shareholders Returns Investors 130

The Motley Fool

SEPTEMBER 25, 2023

And two key players in the cycle are semiconductor equipment leader Lam Research (NASDAQ: LRCX) and Marvell Technology (NASDAQ: MRVL). Meanwhile, Lam Research has broader exposure to the entire sector, but especially AI. LRCX PS Ratio data by YCharts The verdict You can probably tell that I'm more bullish on Lam Research.

Shareholders 130

Shareholders Portfolios Companies Capital 130

Private Equity Professional

FEBRUARY 13, 2024

Linden Capital Partners and Ontario Teachers’ Pension Plan have partnered to launch a new clinical research platform.

Capital 130

Capital Companies 130

The Motley Fool

SEPTEMBER 16, 2023

There are pros and cons to claiming at each age, but research shows there's a clear winner when it comes to making the most of your money. The best age to take Social Security In 2019, researchers at United Income studied retirees' claiming decisions and the amount they collected in benefits over a lifetime. Image source: Getty Images.

Financing 246

Financing Finance 246

The Motley Fool

JULY 19, 2023

Four Harvard researchers recently sided with those who do not believe we're about to witness another housing crash. A 'floor' of factors According to the researchers, today cannot be compared to the mid-2000s crash. Image source: Getty Images Paying attention to housing news today is like watching a tennis match. Here's why.

Accounting 246

Accounting 246

PE Hub

OCTOBER 12, 2023

The post Reynolda Equity Partners takes majority stake in clinical trial site services firm Conquest Research appeared first on PE Hub. Conquest was founded in 2018 by CEO Mark Daley.

Stakes 197

Stakes 197

The Motley Fool

AUGUST 1, 2023

Fool.com contributor Parkev Tatevosian reviews Lam Research 's (NASDAQ: LRCX) June update to determine whether it's a good time for investors to buy the stock. 10 stocks we like better than Lam Research When our analyst team has a stock tip, it can pay to listen. .* and Lam Research wasn't one of them!

Returns 130

Returns Investors Investing 130

PE Hub

AUGUST 28, 2023

The post One Rock invests $500m in landscaping biz, and FFL closes clinical research site deal appeared first on PE Hub. Commercial landscaping services firm BrightView snags $500 million from One Rock.

Investing 196

Investing 196

The Motley Fool

APRIL 16, 2024

Image source: The Motley Fool/Upsplash If you want to make some extra money, starting a side hustle can be a great way to do it. It feels exhilarating and empowering to earn extra cash beyond the limits of your paycheck. And there are more ways than ever to make money with side hustles, especially if you have some in-demand professional skills.

Taxes 246

Taxes Legal Liabilities Financing 246

PE Hub

MAY 31, 2023

Trinity backs clinical research network Centricity. The post Sterling Group’s small-market team launches auto services platform; Trinity Hunt invests in Centricity Research appeared first on PE Hub.

Investing 197

Investing 197